Remove Compounding Remove FDA Remove Magazine
article thumbnail

Mapping the crisis: How data can help fix America’s growing pharmacy deserts

pharmaphorum

These closures, compounded by the decline of independent pharmacies, create a critical gap in care. Image Maggie McCullough 12 June, 2025 pharmacy deserts Bookmark this Oncology ImmunityBio’s ANKTIVA & FDA Expanded Access: Transforming bl. These closures put medication access, affordability, and adherence at greater risk.

article thumbnail

Hims & Hers shares plummet 35% as Novo Nordisk pulls partnership plug

Pharmaceutical Technology

Robert Barrie June 24, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Compounded GLP-1RA medication has become a key revenue driver for Hims & Hers’ telehealth platform. Hims & Hers’ revenue has been soaring on the back of its compounded glucagon-like peptide-1 receptor agonist (GLP-1RA) sales.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Novo Nordisk signs $812m research deal with Deep Apple for non-GLP-1 drugs

Pharmaceutical Technology

Novo Nordisk is eyeing a cardiometabolic drug market future that is not purely dominated by incretins, after signing a $812m partnership with Deep Apple Therapeutics to access novel compounds for obesity and other diseases. Can pharma tariffs “Make America Manufacture Again”?

article thumbnail

Customs simplified: the need to streamline pharma shipments

Pharmaceutical Technology

All pharma shipments must meet strict regulatory requirements that vary significantly between countries, for example Good Manufacturing Practice (GMP) guidelines, which are enforced by entities such as the FDA in the US. Tariffs and trade disputes are further compounding this challenge, affecting the cost structure of pharma businesses.

article thumbnail

Cell and gene therapy: The vital role of logistics

Pharmaceutical Technology

The projected growth of the cell and gene therapy market GlobalData estimates that the cell and gene therapy market will achieve global sales of $76.03bn by 2030, up from $5.88bn in 2023, with a compound annual growth rate (CAGR) of 44% over the seven years analysed. of the global market, valued at $39.3bn.

article thumbnail

Vetter breaks ground on $285m US clinical manufacturing site

Pharmaceutical Technology

The planned 160,000ft² facility will focus on aseptic production and includes areas for material preparation and compounding. How will RFK Jr’s American dream for vaccines play out? Find out more Ground preparation work for the new site commenced in April after obtaining the building permit.

article thumbnail

Why can’t the US figure out weight loss drug prices?

Pharmaceutical Technology

Compounded GLP-1RAs have completely disrupted pricing frameworks for Wegovy and Mounjaro, what happens now? Price differences are especially pertinent with these weight loss drugs, which are officially called glucagon-like peptide-1 receptor agonists (GLP-1RA), due to the emergence of compounded alternatives in the past few years.